OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 2.56 USD 7.56% Market Closed
Market Cap: 43.1m USD
Have any thoughts about
OncoCyte Corp?
Write Note

Wall Street
Price Targets

OCX Price Targets Summary
OncoCyte Corp

Wall Street analysts forecast OCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCX is 4.21 USD with a low forecast of 4.04 USD and a high forecast of 4.46 USD.

Lowest
Price Target
4.04 USD
58% Upside
Average
Price Target
4.21 USD
64% Upside
Highest
Price Target
4.46 USD
74% Upside

OCX Last Price Targets
OncoCyte Corp

The latest public price target was made on Apr 24, 2024 by Mike Matson from Needham , who expects OCX stock to rise by 66% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Mike Matson
Needham
4.25 USD
Upside 66%
9 months ago
Apr 24, 2024
OncoCyte Corp (OCX) PT Raised to $4.25 at Needham
StreetInsider
Mike Matson
Needham
Price Target 4.25 USD
Upside/Downside 66%
View Source
OncoCyte Corp Competitors:
Price Targets
NVAX
Novavax Inc
117% Upside
LXRX
Lexicon Pharmaceuticals Inc
368% Upside
NRIX
Nurix Therapeutics Inc
86% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
25% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
42% Upside
RPTX
Repare Therapeutics Inc
462% Upside
MIRM
Mirum Pharmaceuticals Inc
28% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside

Revenue
Forecast

Revenue Estimate
OncoCyte Corp

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCX's stock price target?
Price Target
4.21 USD

According to Wall Street analysts, the average 1-year price target for OCX is 4.21 USD with a low forecast of 4.04 USD and a high forecast of 4.46 USD.

What is OncoCyte Corp's Revenue forecast?
Projected CAGR
56%

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 56%.

Back to Top